Cargando…

Arterial and venous thromboembolic disease in a patient with COVID-19: A case report

Detalles Bibliográficos
Autores principales:	Brüggemann, Renée, Gietema, Hester, Jallah, Borefore, ten Cate, Hugo, Stehouwer, Coen, Spaetgens, Bart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Letter to the Editors-in-Chief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252130/ https://www.ncbi.nlm.nih.gov/pubmed/32386986 http://dx.doi.org/10.1016/j.thromres.2020.04.046

Ejemplares similares

Incidence of venous and arterial thromboembolic complications in COVID-19: A systematic review and meta-analysis
por: Kunutsor, Setor K., et al.
Publicado: (2020)

Venous thromboembolism and coronavirus disease 2019 in an ambulatory care setting - A report of 4 cases
por: Overstad, Siri, et al.
Publicado: (2020)

Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19
por: Zermatten, Maxime G., et al.
Publicado: (2020)

Managing suspected venous thromboembolism when a pandemic limits diagnostic testing
por: Schaefer, Jordan K., et al.
Publicado: (2020)

A known unknown? Pharmacological prevention of venous thromboembolism in nursing home residents
por: Brüggemann, Renée A. G., et al.
Publicado: (2021)

Utility of D-dimer in predicting venous thromboembolism in non-mechanically ventilated COVID-19 survivors()
por: Nauka, Peter C., et al.
Publicado: (2021)

Bacterial surinfection and venous thromboembolism in critically ill ICU patients with COVID-19: What is the relationship?
por: Stessel, Björn, et al.
Publicado: (2021)

Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?
por: Zuin, Marco, et al.
Publicado: (2021)

D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19
por: Choi, Justin J., et al.
Publicado: (2020)

No evidence of increased rate of thrombotic recurrences in patients with history of venous thromboembolism after vaccination for COVID-19
por: Porfidia, Angelo, et al.
Publicado: (2022)

Incidence of venous thromboembolic events in COVID-19 patients after hospital discharge: A systematic review and meta-analysis
por: Zuin, Marco, et al.
Publicado: (2022)

In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis
por: Mumoli, Nicola, et al.
Publicado: (2021)

COVID-19 associated Venous Thromboembolism (VTE) burden in Black women: Findings of Veterans Affairs COVID-19 Shared Data
por: Choi, Sung-Hee, et al.
Publicado: (2022)

Updated hospital associated venous thromboembolism outcomes with 90-days follow-up after hospitalisation for severe COVID-19 in two UK critical care units
por: Doyle, Andrew J., et al.
Publicado: (2020)

Early thromboembolic events in hospitalized COVID-19 patients
por: Rosen, Raphael J.
Publicado: (2020)

The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome?
por: Previtali, Giulia, et al.
Publicado: (2020)

Thromboembolic events related to atrial fibrillation during the COVID-19 epidemic in Denmark
por: Rasmussen, Peter Vibe, et al.
Publicado: (2020)

Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study
por: van Haaps, Thijs F., et al.
Publicado: (2021)

Extensive pulmonary perfusion defects compatible with microthrombosis and thromboembolic disease in severe Covid-19 pneumonia
por: Beenen, L.F.M., et al.
Publicado: (2020)

Comparison of IMPROVE, modified IMPROVE, IMPROVEDD, Padua and CHA2DS2-VASC risk scores for venous and arterial thrombotic events prediction in hospitalized COVID-19 patients
por: Lucijanic, Marko, et al.
Publicado: (2022)

Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination
por: Franchini, Massimo, et al.
Publicado: (2021)

Safety of COVID-19 vaccination in patients with previous cerebral venous sinus thrombosis
por: Gil-Díaz, Aída, et al.
Publicado: (2022)

The long haul COVID-19 arterial thrombosis
por: Borrelli, Maria Pia, et al.
Publicado: (2022)

In situ immune-mediated pulmonary artery thrombosis and Covid-19 pneumonitis
por: Mandal, Amit K.J., et al.
Publicado: (2021)

Long VITT: A case report
por: Roberge, Guillaume, et al.
Publicado: (2023)

Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case
por: Hindilerden, Fehmi, et al.
Publicado: (2020)

Prevalence of venous obstructions in (recurrent) venous thromboembolism: a case-control study
por: Notten, Pascale, et al.
Publicado: (2020)

Clinical course, management, and platelet activity assessment of splanchnic VITT: A case report
por: Corica, Bernadette, et al.
Publicado: (2021)

Association between SARS-CoV-2 infection or vaccination and acquired hemophilia A: A case report and literature update
por: Franchini, Massimo, et al.
Publicado: (2023)

Increased prevalence of VTE reported by Klok and colleagues, the numbers don't add up
por: Greenstein, Yonatan Y.
Publicado: (2020)

“COVID-19 associated divergent thrombotic thrombocytopenic purpura (TTP) syndromes reported so far, five and counting”: Classification and possible therapeutic options
por: Mir, Tajamul H.
Publicado: (2022)

Asymptomatic deep vein thrombosis in critically ill COVID-19 patients despite therapeutic levels of anti-Xa activity
por: Torres-Machorro, Adriana, et al.
Publicado: (2020)

Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care
por: Thomas, W., et al.
Publicado: (2020)

The prevalence of pulmonary embolism in patients with COVID-19 and respiratory decline: A three-setting comparison
por: Brüggemann, Renée A.G., et al.
Publicado: (2020)

Portal vein thrombosis in a patient with COVID-19
por: Franco-Moreno, A., et al.
Publicado: (2020)

Pulmonary embolism in a young pregnant woman with COVID-19
por: Martinelli, Ida, et al.
Publicado: (2020)

Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit?
por: Kollias, Anastasios, et al.
Publicado: (2021)

Heparin-induced thrombocytopenia and thrombosis in a patient with Covid-19()
por: Huang, Ching-Tai, et al.
Publicado: (2020)

A comprehensive assessment of the coagulation profile in critically ill COVID-19 patients
por: Adam, E.H., et al.
Publicado: (2020)

Occurrence of pulmonary embolism in a patient with mild clinical expression of COVID-19
por: Vitali, Claudio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lka24d7uae3joemjj763tn3jh0